US 11679143
FGF21 variant, fusion protein and application thereof
granted A61KA61K38/00A61K38/1825
Quick answer
US patent 11679143 (FGF21 variant, fusion protein and application thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61K38/1825, A61K38/26, A61K47/6811